| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 4 |
| 1 | OMEPRAZOLE | 3 |
| 2 | OMEPRAZOLE MAGNESIUM | 3 |
| 3 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 |
| 4 | ACETAMINOPHEN | 2 |
| 5 | ACETAMINOPHEN 500MG | 2 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 7 | APIXABAN | 2 |
| 8 | ASPIRIN | 2 |
| 9 | ASPIRIN 325 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXACILLIN SODIUM | 1 | 0.0009 |
| 1 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 | 0.0008 |
| 2 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 3 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 4 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 1 | 0.0006 |
| 5 | DAPRODUSTAT | 1 | 0.0005 |
| 6 | NICARDIPINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | DONANEMAB-AZBT | 1 | 0.0003 |
| 8 | VERAPAMIL HYDROCHLORIDE | 1 | 0.0002 |
| 9 | NICARDIPINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 6 | Anticholinergic [EPC] | 1 | 0.0001 |
| 7 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |